These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12660833)

  • 1. Binding of bis-beta-chloroethylamine derivatives of synthetic estrogens to proteins: dependence on the chemical structure.
    Mayatskaya EE; Semeikin AV; Rzheznikov VM; Shimanovskii NL
    Bull Exp Biol Med; 2002 Dec; 134(6):544-7. PubMed ID: 12660833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of synthetic bis-beta-chloroethylamine estrogen derivatives on proliferation of skin sarcoma cells.
    Semeikin AV; Rzheznikov VM; Mayatskaya EE; Smirnova ZS
    Bull Exp Biol Med; 2000 Jun; 129(6):592-4. PubMed ID: 11022259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of estrogen cytostatics on activity of plasma membrane enzymes 5'-nucleotidase and N+-K+-ATPase.
    Mayatskaya EE; Semeikin AV; Rzheznikov VM; Shimanovskii NL
    Bull Exp Biol Med; 2003 Dec; 136(6):557-9. PubMed ID: 15500070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of bis-beta-chloroethylamine estrogen derivatives and doxorubicin on proliferation of sensitive and resistant MCF-7 cells.
    Mayatskaya EE; Shimanovskii NL; Banin VV; Fedotcheva TA; Semeikin AV; Rzheznikov VM
    Bull Exp Biol Med; 2007 Mar; 143(3):334-6. PubMed ID: 18225756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doisynolic-type acids--uterotropically potent estrogens which compete poorly with estradiol for cytosolic estradiol receptors.
    Meyers CY; Kolb VM; Gass GH; Rao BR; Roos CF; Dandliker WB
    J Steroid Biochem; 1988 Oct; 31(4A):393-404. PubMed ID: 3172773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
    Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
    J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells.
    Hansen ER; Brooks SC
    Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the estrogenic activity of modified estrogens based on data of competitive binding analysis and biological assay].
    Pokrovskaia EV; Ivanenko TI
    Probl Endokrinol (Mosk); 1981; 27(6):66-70. PubMed ID: 7323033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of triphenylacrylonitrile derivatives on estradiol-receptor binding and on human breast cancer cell growth.
    Bignon E; Pons M; Crastes de Paulet AC; Doré JC; Gilbert J; Abecassis J; Miquel JF; Ojasoo T; Raynaud JP
    J Med Chem; 1989 Sep; 32(9):2092-103. PubMed ID: 2769681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis.
    Liu R; Yang SH; Perez E; Yi KD; Wu SS; Eberst K; Prokai L; Prokai-Tatrai K; Cai ZY; Covey DF; Day AL; Simpkins JW
    Stroke; 2002 Oct; 33(10):2485-91. PubMed ID: 12364742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens.
    Heiman DF; Senderoff SG; Katzenellenbogen JA; Neeley RJ
    J Med Chem; 1980 Sep; 23(9):994-1002. PubMed ID: 7411555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The steroid specificity of the estrogen-receptor of human breast carcinoma.
    Hähnel R; Twaddle E
    J Steroid Biochem; 1974 Apr; 5(2):119-22. PubMed ID: 4366805
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthetic estrogens--new pharmacological actions and mechanisms].
    Kosano H; Nishigori H
    Nihon Rinsho; 1994 Mar; 52(3):587-92. PubMed ID: 8164354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential stimulation by 17 beta-estradiol and synthetic estrogens of progesterone-receptor and of translocation of estrogen-receptor in rat pituitary and uterus.
    Leibl H; Spona J
    Endocrinology; 1982 Jan; 110(1):265-71. PubMed ID: 7053987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Properties of alkylating derivatives of estrogens].
    Morozova TM; Merkulova TI; Martynov V; Iaguzhinskaia VP; Shkodinskaia EN
    Eksp Onkol; 1984; 6(2):50-4. PubMed ID: 6510335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The modulators of the estrogenic activity].
    Kirkiacharian S
    Ann Pharm Fr; 2000 Dec; 58(6):383-91. PubMed ID: 11148373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-like compounds for ischemic neuroprotection.
    Simpkins JW; Yang SH; Liu R; Perez E; Cai ZY; Covey DF; Green PS
    Stroke; 2004 Nov; 35(11 Suppl 1):2648-51. PubMed ID: 15472107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor assay in human mammary carcinoma with the synthetic estrogen 11beta-methoxy-17alpha-ethinyl-1,3,5(10)-estratriene-3,17beta-diol (R 2858).
    Okret S; Wrange O; Nordenskjöld B; Silfverswärd C; Gustafsson JA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3904-9. PubMed ID: 568028
    [No Abstract]   [Full Text] [Related]  

  • 20. Calciumantagonistic effect of natural and synthetic estrogens--investigations on a nongenomic mechanism of direct vascular action.
    Mueck AO; Seeger H; Lippert TH
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):424-6. PubMed ID: 8897079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.